Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing - PressReach

pressreach.com

Factuality

Ownership

Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing - PressReach

Funding will accelerate the company’s anti-amyloid treatment for rare and common forms of dementia. As well as bringing forward a new class of treatment for inflammatory skin diseases. Sanos Group CEO Jeppe Ragnar Andersen joins the board. REYKJAVIK, Iceland and PHILADELPHIA, Jan. 22, 2025 /PRNewswire/ — Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the successful closing of a €26.5 million oversubscr…

european-biotechnology.com

Factuality

Ownership

Arctic Therapeutics ASA kicks off with €26.5m Series A round - European Biotechnology Magazine

Iceland's Arctic Therapeutics has secured €26.5m in a Series A financing aimed to push its oral drug candidates AT-O01 and AT-004 into clinical trails in patients with rare amyloid aggregation diseases including Alzheimer's disease. The post Arctic Therapeutics ASA kicks off with €26.5m Series A round appeared first on European Biotechnology Magazine.

FinSMEs

Factuality

Ownership

Arctic Therapeutics, a Reykjavik, Iceland-based drug discovery and development company, raised €26.5M in Series A funding.

Arctic Therapeutics, a Reykjavik, Iceland-based drug discovery and development company, raised €26.5M in Series A funding. Backers included EIC Fund, Kaldbakur, Sanos Group, Cerebrum DAO, The Lurie Family Foundation, as well as a consortium led by early investors and co-founders of Icelandic unicorn such as Kerecis and Chemometec. Icelandic institutional investors and family offices also […] The post Arctic Therapeutics Raises €26.5M in Series A…

Vísir

Factuality

Ownership

Icelandic genetic and biotechnology company Arctic Therapeutics has completed a capital increase of approximately ISK 4 billion from a broad group of domestic and international investors, including the Samherji family investment company and the Nordic research group Sanos Group. The funding will ensure the company can begin clinical trials of drugs for dementia and inflammatory skin diseases.

fundingblogger.com

Factuality

Ownership

Arctic Therapeutics Secures €26.5M Series A Funding

Arctic Therapeutics (ATx), an Icelandic drug discovery and development startup, has announced the successful closure of a €26.5 million Series A financing round. The funding, supported by a diverse syndicate of international investors, marks a significant milestone in the company’s mission to develop innovative treatments for neurodegenerative diseases and inflammatory conditions. The investment round saw participation from the EIC Fund, Iceland…